Dr. Zloza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1735 W Harrison St
Room 316
Chicago, IL 60612Phone+1 312-942-2321
Education & Training
- Rush Medical College of Rush University Medical CenterClass of 2009
Publications & Presentations
PubMed
- 8 citationsCD8+ T Cells Sabotage Their Own Memory Potential through IFN-γ–Dependent Modification of the IL-12/IL-15 Receptor α Axis on Dendritic CellsFrederick J. Kohlhapp, Andrew Zloza, Jeremy A. O'Sullivan, Tamson V. Moore, Andrew T. Lacek
Journal of Immunology. 2012-04-15 - 100 citationsOncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.Sachin R. Jhawar, Aditya Thandoni, Praveen K. Bommareddy, Suemair Hassan, Frederick J. Kohlhapp
Frontiers in Oncology. 2017-09-11 - 447 citationsOncolytic viruses: a new class of immunotherapy drugs.Howard L Kaufman, Frederick J Kohlhapp, Andrew Zloza
Nature Reviews. Drug Discovery. 2015-09-01
Press Mentions
- An Early Study Suggests the Flu Shot Could Someday Be Used as Part of an Immunotherapy Regimen in CancerFebruary 12th, 2020
- Flu Vaccines May Shrink Tumors and Boost Cancer TreatmentJanuary 11th, 2020
- Can the Flu Shot Help Fight Cancer?January 7th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: